Breast Cancer Res Treat. 2011 May;127(1):133-42. doi: 10.1007/s10549-010-1331-z. Epub 2011 Jan 11.
3
Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from the randomized phase III TAnDEM study.
曲妥珠单抗联合阿那曲唑对比阿那曲唑单药治疗人表皮生长因子受体 2 阳性、激素受体阳性转移性乳腺癌绝经后女性患者：来自随机 III 期 TAnDEM 研究的结果。
